_id
69109633ccc777a4e85d5b41
Ticker
ELVN
Name
Enliven Therapeutics Inc.
Exchange
NASDAQ
Address
6200 Lookout Road, Boulder, CO, United States, 80301
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.enliventherapeutics.com
Description
Enliven Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients with cancer. The company's lead product candidates comprise ELVN-001, a small molecule kinase inhibitor which is in Phase 1 clinical trial to treat adults with chronic myeloid leukemia; and ELVN-002, a CNS penetrant and irreversible HER2 inhibitor that is in Phase 1 clinical trial for the treatment of non-small cell lung cancer (NSCLC) and other HER2 driven cancers and solid tumors. The company is headquartered in Boulder, Colorado.
Last Close
15.5
Volume
490849
Current Price
15.1699
Change
0.14
Last Updated
2026-01-03T10:56:03.646Z
Image
data:image/webp;base64,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
Ipo Date
2020-03-12T00:00:00.000Z
Market Cap
922257280
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.785
Sentiment Sources
1
Rating
4.875
Target Price
41.375
Strong Buy
7
Buy
1
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
25096000
Operating Income
-25096000
Interest Expense
-
Pretax Income
-20148000
Net Income
-20148000
Eps
-0.3244768660056935
Dividends Per Share
-
Shares Outstanding
59347317
Income Tax Expense
-
EBITDA
-20086000
Operating Margin
-
Total Other Income Expense Net
4948000
Cash
101732000
Short Term Investments
375833000
Receivables
-
Inventories
-
Total Current Assets
482683000
Property Plant Equipment
874000
Total Assets
490875000
Payables
1429000
Short Term Debt
387000
Long Term Debt
-
Total Liabilities
14753000
Equity
476122000
Bs_currency_symbol
USD
Depreciation
62000
Change In Working Capital
-157000
Cash From Operations
-13279000
Capital Expenditures
1000
Cash From Investing
-4058000
Cash From Financing
-368000
Net Change In Cash
-17705000
Cf_currency_symbol
USD
PE
-
PB
1.9783934806005603
ROE
-4.231688516808717
ROA
-4.104507257448434
FCF
-13280000
Fcf Percent
-
Piotroski FScore
1
Health Score
43
Deep Value Investing Score
3.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
2
Net Net Investing Score
2.5
Quality Investing Score
2.5
Value Investing Score
4
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
25096000
Quarters > 0 > income Statement > operating Income
-25096000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-20148000
Quarters > 0 > income Statement > net Income
-20148000
Quarters > 0 > income Statement > eps
-0.3244768660056935
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
62093795
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-20086000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
4948000
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
101732000
Quarters > 0 > balance Sheet > short Term Investments
375833000
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
482683000
Quarters > 0 > balance Sheet > property Plant Equipment
874000
Quarters > 0 > balance Sheet > total Assets
490875000
Quarters > 0 > balance Sheet > payables
1429000
Quarters > 0 > balance Sheet > short Term Debt
387000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
14753000
Quarters > 0 > balance Sheet > equity
476122000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-20148000
Quarters > 0 > cash Flow > depreciation
62000
Quarters > 0 > cash Flow > change In Working Capital
-157000
Quarters > 0 > cash Flow > cash From Operations
-13279000
Quarters > 0 > cash Flow > capital Expenditures
1000
Quarters > 0 > cash Flow > cash From Investing
-4058000
Quarters > 0 > cash Flow > cash From Financing
-368000
Quarters > 0 > cash Flow > net Change In Cash
-17705000
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.3244768660056935
Quarters > 0 > ratios > PB
1.9783934806005603
Quarters > 0 > ratios > ROE
-4.231688516808717
Quarters > 0 > ratios > ROA
-4.104507257448434
Quarters > 0 > ratios > FCF
-13280000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
43
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
81000
Quarters > 1 > income Statement > gross Profit
-81000
Quarters > 1 > income Statement > operating Expenses
28584000
Quarters > 1 > income Statement > operating Income
-28584000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-25335000
Quarters > 1 > income Statement > net Income
-25335000
Quarters > 1 > income Statement > eps
-0.48622924318355926
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
52105052
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-28503000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
3249000
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
119437000
Quarters > 1 > balance Sheet > short Term Investments
371066000
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
495622000
Quarters > 1 > balance Sheet > property Plant Equipment
1026000
Quarters > 1 > balance Sheet > total Assets
503887000
Quarters > 1 > balance Sheet > payables
2351000
Quarters > 1 > balance Sheet > short Term Debt
376000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
15415000
Quarters > 1 > balance Sheet > equity
488472000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-25335000
Quarters > 1 > cash Flow > depreciation
154000
Quarters > 1 > cash Flow > change In Working Capital
313000
Quarters > 1 > cash Flow > cash From Operations
-17057000
Quarters > 1 > cash Flow > capital Expenditures
139000
Quarters > 1 > cash Flow > cash From Investing
-183589000
Quarters > 1 > cash Flow > cash From Financing
218378000
Quarters > 1 > cash Flow > net Change In Cash
17732000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.48622924318355926
Quarters > 1 > ratios > PB
1.6181652752559001
Quarters > 1 > ratios > ROE
-5.18658183068835
Quarters > 1 > ratios > ROA
-5.027913004304536
Quarters > 1 > ratios > FCF
-17196000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
43
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
74000
Quarters > 2 > income Statement > gross Profit
-74000
Quarters > 2 > income Statement > operating Expenses
31693000
Quarters > 2 > income Statement > operating Income
-31693000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-28544000
Quarters > 2 > income Statement > net Income
-28544000
Quarters > 2 > income Statement > eps
-0.5702982957383469
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
50051000
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-31619000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
3149000
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
101705000
Quarters > 2 > balance Sheet > short Term Investments
187850000
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
294318000
Quarters > 2 > balance Sheet > property Plant Equipment
1055000
Quarters > 2 > balance Sheet > total Assets
302570000
Quarters > 2 > balance Sheet > payables
1562000
Quarters > 2 > balance Sheet > short Term Debt
365000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
14274000
Quarters > 2 > balance Sheet > equity
288296000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-28544000
Quarters > 2 > cash Flow > depreciation
74000
Quarters > 2 > cash Flow > change In Working Capital
-2496000
Quarters > 2 > cash Flow > cash From Operations
-24127000
Quarters > 2 > cash Flow > capital Expenditures
20000
Quarters > 2 > cash Flow > cash From Investing
1427000
Quarters > 2 > cash Flow > cash From Financing
234000
Quarters > 2 > cash Flow > net Change In Cash
-22466000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.5702982957383469
Quarters > 2 > ratios > PB
2.6336427314288096
Quarters > 2 > ratios > ROE
-9.900935149984738
Quarters > 2 > ratios > ROA
-9.433850018177612
Quarters > 2 > ratios > FCF
-24147000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
43
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
316000
Quarters > 3 > income Statement > cost Of Revenue
158000
Quarters > 3 > income Statement > gross Profit
158000
Quarters > 3 > income Statement > operating Expenses
26896000
Quarters > 3 > income Statement > operating Income
-26896000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-23180000
Quarters > 3 > income Statement > net Income
-23180000
Quarters > 3 > income Statement > eps
-0.46492037386176743
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
49858000
Quarters > 3 > income Statement > income Tax Expense
-500000
Quarters > 3 > income Statement > EBITDA
-26816000
Quarters > 3 > income Statement > operating Margin
-8511.392405063292
Quarters > 3 > income Statement > total Other Income Expense Net
3716000
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
124117000
Quarters > 3 > balance Sheet > short Term Investments
189323000
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
318127000
Quarters > 3 > balance Sheet > property Plant Equipment
458000
Quarters > 3 > balance Sheet > total Assets
325760000
Quarters > 3 > balance Sheet > payables
1342000
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
15915000
Quarters > 3 > balance Sheet > equity
309845000
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-23180000
Quarters > 3 > cash Flow > depreciation
80000
Quarters > 3 > cash Flow > change In Working Capital
-510000
Quarters > 3 > cash Flow > cash From Operations
-17203000
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
727000
Quarters > 3 > cash Flow > cash From Financing
39972000
Quarters > 3 > cash Flow > net Change In Cash
23496000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.46492037386176743
Quarters > 3 > ratios > PB
2.441029786506156
Quarters > 3 > ratios > ROE
-7.481159934806112
Quarters > 3 > ratios > ROA
-7.115667976424361
Quarters > 3 > ratios > FCF
-17203000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-54.43987341772152
Quarters > 3 > health Score
35
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
317000
Annuals > 0 > income Statement > gross Profit
-317000
Annuals > 0 > income Statement > operating Expenses
104554000
Annuals > 0 > income Statement > operating Income
-104554000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-88792000
Annuals > 0 > income Statement > net Income
-89024000
Annuals > 0 > income Statement > eps
-1.8911902789284727
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
47073000
Annuals > 0 > income Statement > income Tax Expense
232000
Annuals > 0 > income Statement > EBITDA
-104237000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
15762000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
124117000
Annuals > 0 > balance Sheet > short Term Investments
189323000
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
318127000
Annuals > 0 > balance Sheet > property Plant Equipment
458000
Annuals > 0 > balance Sheet > total Assets
325760000
Annuals > 0 > balance Sheet > payables
1342000
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
15915000
Annuals > 0 > balance Sheet > equity
309845000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-89024000
Annuals > 0 > cash Flow > depreciation
317000
Annuals > 0 > cash Flow > change In Working Capital
-4541000
Annuals > 0 > cash Flow > cash From Operations
-73192000
Annuals > 0 > cash Flow > capital Expenditures
44000
Annuals > 0 > cash Flow > cash From Investing
-35997000
Annuals > 0 > cash Flow > cash From Financing
133165000
Annuals > 0 > cash Flow > net Change In Cash
23976000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-1.8911902789284727
Annuals > 0 > ratios > PB
2.3609043876777096
Annuals > 0 > ratios > ROE
-28.731785247462444
Annuals > 0 > ratios > ROA
-27.328094302554028
Annuals > 0 > ratios > FCF
-73236000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
34
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
297000
Annuals > 1 > income Statement > gross Profit
-297000
Annuals > 1 > income Statement > operating Expenses
83529000
Annuals > 1 > income Statement > operating Income
-83529000
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-71584000
Annuals > 1 > income Statement > net Income
-71584000
Annuals > 1 > income Statement > eps
-2.0138412198278286
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
35546000
Annuals > 1 > income Statement > income Tax Expense
1300000
Annuals > 1 > income Statement > EBITDA
-83232000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
11945000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
100141000
Annuals > 1 > balance Sheet > short Term Investments
153007000
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
266151000
Annuals > 1 > balance Sheet > property Plant Equipment
1062000
Annuals > 1 > balance Sheet > total Assets
271867000
Annuals > 1 > balance Sheet > payables
532000
Annuals > 1 > balance Sheet > short Term Debt
335000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
25961000
Annuals > 1 > balance Sheet > equity
245906000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-71584000
Annuals > 1 > cash Flow > depreciation
297000
Annuals > 1 > cash Flow > change In Working Capital
1401000
Annuals > 1 > cash Flow > cash From Operations
-61269000
Annuals > 1 > cash Flow > capital Expenditures
149000
Annuals > 1 > cash Flow > cash From Investing
-148412000
Annuals > 1 > cash Flow > cash From Financing
234286000
Annuals > 1 > cash Flow > net Change In Cash
24605000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-2.0138412198278286
Annuals > 1 > ratios > PB
2.246325181166787
Annuals > 1 > ratios > ROE
-29.11031044382813
Annuals > 1 > ratios > ROA
-26.330521909610216
Annuals > 1 > ratios > FCF
-61418000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
34
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
622000
Annuals > 2 > income Statement > gross Profit
-622000
Annuals > 2 > income Statement > operating Expenses
38791000
Annuals > 2 > income Statement > operating Income
-38791000
Annuals > 2 > income Statement > interest Expense
1217000
Annuals > 2 > income Statement > pretax Income
-37662000
Annuals > 2 > income Statement > net Income
-37662000
Annuals > 2 > income Statement > eps
-6.026884301488238
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
6249000
Annuals > 2 > income Statement > income Tax Expense
88000
Annuals > 2 > income Statement > EBITDA
-38576000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
1129000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
75536000
Annuals > 2 > balance Sheet > short Term Investments
0
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
77753000
Annuals > 2 > balance Sheet > property Plant Equipment
1516000
Annuals > 2 > balance Sheet > total Assets
83298000
Annuals > 2 > balance Sheet > payables
3438000
Annuals > 2 > balance Sheet > short Term Debt
323000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
160123000
Annuals > 2 > balance Sheet > equity
-76825000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-37662000
Annuals > 2 > cash Flow > depreciation
215000
Annuals > 2 > cash Flow > change In Working Capital
438000
Annuals > 2 > cash Flow > cash From Operations
-32077000
Annuals > 2 > cash Flow > capital Expenditures
612000
Annuals > 2 > cash Flow > cash From Investing
-612000
Annuals > 2 > cash Flow > cash From Financing
-1799000
Annuals > 2 > cash Flow > net Change In Cash
-34488000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-6.026884301488238
Annuals > 2 > ratios > PB
-1.2640346241457858
Annuals > 2 > ratios > ROE
49.023104458184186
Annuals > 2 > ratios > ROA
-45.21357055391486
Annuals > 2 > ratios > FCF
-32689000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
30
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
99000
Annuals > 3 > income Statement > gross Profit
-99000
Annuals > 3 > income Statement > operating Expenses
24762000
Annuals > 3 > income Statement > operating Income
-24762000
Annuals > 3 > income Statement > interest Expense
93000
Annuals > 3 > income Statement > pretax Income
-24740000
Annuals > 3 > income Statement > net Income
-24740000
Annuals > 3 > income Statement > eps
-3.165706973768394
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
7815000
Annuals > 3 > income Statement > income Tax Expense
-22000
Annuals > 3 > income Statement > EBITDA
-24647000
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
22000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
110024000
Annuals > 3 > balance Sheet > short Term Investments
41969000
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
110670000
Annuals > 3 > balance Sheet > property Plant Equipment
954000
Annuals > 3 > balance Sheet > total Assets
113329000
Annuals > 3 > balance Sheet > payables
2521000
Annuals > 3 > balance Sheet > short Term Debt
159000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
6467000
Annuals > 3 > balance Sheet > equity
106862000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-24740000
Annuals > 3 > cash Flow > depreciation
115000
Annuals > 3 > cash Flow > change In Working Capital
3567000
Annuals > 3 > cash Flow > cash From Operations
-19134000
Annuals > 3 > cash Flow > capital Expenditures
191000
Annuals > 3 > cash Flow > cash From Investing
-191000
Annuals > 3 > cash Flow > cash From Financing
-1016000
Annuals > 3 > cash Flow > net Change In Cash
-20341000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-3.165706973768394
Annuals > 3 > ratios > PB
1.1364666579326608
Annuals > 3 > ratios > ROE
-23.151354082835805
Annuals > 3 > ratios > ROA
-21.83024645059958
Annuals > 3 > ratios > FCF
-19325000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
34
Valuation > metrics > PE
-0.3244768660056935
Valuation > metrics > PB
1.9783934806005603
Valuation > final Score
80
Valuation > verdict
Fair
Profitability > metrics > ROE
-4.231688516808717
Profitability > metrics > ROA
-4.1741681393378265
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.030985755751677092
Risk > metrics > Interest Coverage
-404.7741935483871
Risk > final Score
-1559
Risk > verdict
High
Liquidity > metrics > Current Ratio
265.7946035242291
Liquidity > metrics > Quick Ratio
265.7946035242291
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
80
Prev Valuations > 1
80
Prev Valuations > 2
80
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
0
Prev Risks > 0
24
Prev Risks > 1
19
Prev Risks > 2
30
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T21:46:20.420Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-12
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
-0.3778
Earnings History > 0 > eps Difference
0.3778
Earnings History > 0 > surprise Percent
100
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-11-12
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.32
Earnings History > 1 > eps Estimate
-0.5
Earnings History > 1 > eps Difference
0.18
Earnings History > 1 > surprise Percent
36
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-08-13
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.49
Earnings History > 2 > eps Estimate
-0.55
Earnings History > 2 > eps Difference
0.06
Earnings History > 2 > surprise Percent
10.9091
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-05-12
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.57
Earnings History > 3 > eps Estimate
-0.5043
Earnings History > 3 > eps Difference
-0.0657
Earnings History > 3 > surprise Percent
-13.028
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2025-03-12
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.46
Earnings History > 4 > eps Estimate
-0.5175
Earnings History > 4 > eps Difference
0.0575
Earnings History > 4 > surprise Percent
11.1111
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-11-07
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.4782
Earnings History > 5 > eps Estimate
-0.5
Earnings History > 5 > eps Difference
0.0218
Earnings History > 5 > surprise Percent
4.36
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-08-13
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.41
Earnings History > 6 > eps Estimate
-0.55
Earnings History > 6 > eps Difference
0.14
Earnings History > 6 > surprise Percent
25.4545
Earnings History > 7 > period
2024-03-31
Earnings History > 7 > report Date
2024-05-14
Earnings History > 7 > date
2024-03-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.54
Earnings History > 7 > eps Estimate
-0.57
Earnings History > 7 > eps Difference
0.03
Earnings History > 7 > surprise Percent
5.2632
Earnings History > 8 > period
2023-12-31
Earnings History > 8 > report Date
2024-03-14
Earnings History > 8 > date
2023-12-31
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.47
Earnings History > 8 > eps Estimate
-0.54
Earnings History > 8 > eps Difference
0.07
Earnings History > 8 > surprise Percent
12.963
Earnings History > 9 > period
2023-09-30
Earnings History > 9 > report Date
2023-11-09
Earnings History > 9 > date
2023-09-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.51
Earnings History > 9 > eps Estimate
-0.47
Earnings History > 9 > eps Difference
-0.04
Earnings History > 9 > surprise Percent
-8.5106
Earnings History > 10 > period
2023-06-30
Earnings History > 10 > report Date
2023-08-10
Earnings History > 10 > date
2023-06-30
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.41
Earnings History > 10 > eps Estimate
-0.36
Earnings History > 10 > eps Difference
-0.05
Earnings History > 10 > surprise Percent
-13.8889
Earnings History > 11 > period
2023-03-31
Earnings History > 11 > report Date
2023-05-11
Earnings History > 11 > date
2023-03-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.8
Earnings History > 11 > eps Estimate
-0.63
Earnings History > 11 > eps Difference
-0.17
Earnings History > 11 > surprise Percent
-26.9841
Earnings History > 12 > period
2022-12-31
Earnings History > 12 > report Date
2023-02-10
Earnings History > 12 > date
2022-12-31
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
1.21
Earnings History > 12 > eps Estimate
-0.786
Earnings History > 12 > eps Difference
1.996
Earnings History > 12 > surprise Percent
253.944
Earnings History > 13 > period
2022-09-30
Earnings History > 13 > report Date
2022-10-25
Earnings History > 13 > date
2022-09-30
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.72
Earnings History > 13 > eps Estimate
-1
Earnings History > 13 > eps Difference
0.28
Earnings History > 13 > surprise Percent
28
Earnings History > 14 > period
2022-06-30
Earnings History > 14 > report Date
2022-08-03
Earnings History > 14 > date
2022-06-30
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-1.76
Earnings History > 14 > eps Estimate
-2.05
Earnings History > 14 > eps Difference
0.29
Earnings History > 14 > surprise Percent
14.1463
Earnings History > 15 > period
2022-03-31
Earnings History > 15 > report Date
2022-05-06
Earnings History > 15 > date
2022-03-31
Earnings History > 15 > before After Market
BeforeMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-2.24
Earnings History > 15 > eps Estimate
-2.31
Earnings History > 15 > eps Difference
0.07
Earnings History > 15 > surprise Percent
3.0303
Earnings History > 16 > period
2021-12-31
Earnings History > 16 > report Date
2022-03-15
Earnings History > 16 > date
2021-12-31
Earnings History > 16 > before After Market
BeforeMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-2.12
Earnings History > 16 > eps Estimate
-3
Earnings History > 16 > eps Difference
0.88
Earnings History > 16 > surprise Percent
29.3333
Earnings History > 17 > period
2021-09-30
Earnings History > 17 > report Date
2021-11-09
Earnings History > 17 > date
2021-09-30
Earnings History > 17 > before After Market
BeforeMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-2.2
Earnings History > 17 > eps Estimate
-3.38
Earnings History > 17 > eps Difference
1.18
Earnings History > 17 > surprise Percent
34.9112
Earnings History > 18 > period
2021-06-30
Earnings History > 18 > report Date
2021-08-06
Earnings History > 18 > date
2021-06-30
Earnings History > 18 > before After Market
BeforeMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-2.96
Earnings History > 18 > eps Estimate
-3.2
Earnings History > 18 > eps Difference
0.24
Earnings History > 18 > surprise Percent
7.5
Earnings History > 19 > period
2021-03-31
Earnings History > 19 > report Date
2021-05-11
Earnings History > 19 > date
2021-03-31
Earnings History > 19 > before After Market
BeforeMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-2.32
Earnings History > 19 > eps Estimate
-3.34
Earnings History > 19 > eps Difference
1.02
Earnings History > 19 > surprise Percent
30.5389
Earnings History > 20 > period
2020-12-31
Earnings History > 20 > report Date
2021-03-05
Earnings History > 20 > date
2020-12-31
Earnings History > 20 > before After Market
BeforeMarket
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-2.24
Earnings History > 20 > eps Estimate
-3.35
Earnings History > 20 > eps Difference
1.11
Earnings History > 20 > surprise Percent
33.1343
Earnings History > 21 > period
2020-09-30
Earnings History > 21 > report Date
2020-11-05
Earnings History > 21 > date
2020-09-30
Earnings History > 21 > before After Market
BeforeMarket
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-2.88
Earnings History > 21 > eps Estimate
-3.21
Earnings History > 21 > eps Difference
0.33
Earnings History > 21 > surprise Percent
10.2804
Earnings History > 22 > period
2020-06-30
Earnings History > 22 > report Date
2020-08-14
Earnings History > 22 > date
2020-06-30
Earnings History > 22 > before After Market
BeforeMarket
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-2.36
Earnings History > 22 > eps Estimate
-2.25
Earnings History > 22 > eps Difference
-0.11
Earnings History > 22 > surprise Percent
-4.8889
Earnings History > 23 > period
2020-03-31
Earnings History > 23 > report Date
2020-05-07
Earnings History > 23 > date
2020-03-31
Earnings History > 23 > before After Market
BeforeMarket
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-17.24
Earnings History > 23 > eps Estimate
-2.94
Earnings History > 23 > eps Difference
-14.3
Earnings History > 23 > surprise Percent
-486.3946
Earnings History > 24 > period
2019-12-31
Earnings History > 24 > report Date
2020-03-11
Earnings History > 24 > date
2019-12-31
Earnings History > 24 > before After Market
AfterMarket
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
-0.68
Earnings History > 24 > eps Estimate
0
Earnings History > 24 > eps Difference
-0.68
Earnings History > 24 > surprise Percent
-
Earnings History > 25 > period
2019-09-30
Earnings History > 25 > report Date
2019-10-08
Earnings History > 25 > date
2019-09-30
Earnings History > 25 > before After Market
-
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
-0.32
Earnings History > 25 > eps Estimate
0
Earnings History > 25 > eps Difference
-0.32
Earnings History > 25 > surprise Percent
-
Enliven Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients with cancer. The company's lead product candidates comprise ELVN-001, a small molecule kinase inhibitor which is in Phase 1 clinical trial to treat adults with chronic myeloid leukemia; and ELVN-002, a CNS penetrant and irreversible HER2 inhibitor that is in Phase 1 clinical trial for the treatment of non-small cell lung cancer (NSCLC) and other HER2 driven cancers and solid tumors. The company is headquartered in Boulder, Colorado.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AComparing CytoDyn (OTCMKTS:CYDY) and Enliven Therapeutics (NASDAQ:ELVN) Defense World
Read more →Stocks To Watch: Enliven Therapeutics Sees RS Rating Jump To 85 - Investor's Business Daily
1/20/2026
Stocks To Watch: Enliven Therapeutics Sees RS Rating Jump To 85 Investor's Business Daily
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$41.375
Analyst Picks
Strong Buy
7
Buy
1
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Medium
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Enliven Therapeutics Inc.
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
-0.3778
Date
2025-09-30
EPS Actual
-0.32
EPS Estimate
-0.5
EPS Difference
0.18
Surprise Percent
36%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.